Analysis for HCA

📈 Growth & Financial Trajectory

Over the eight quarters, Revenues rose from about $17.34B in 2024 Q1 to $20.23B in 2026 Q2, a cumulative increase of roughly 16-17%. Net income rose from about $1.80B to $1.93B, up about 7%, with quarterly volatility but an overall uptrend. The trajectory shows durable top-line growth and a modest expansion in profitability.

💰 Margins & Cash Flow

Gross margin has hovered in the mid to high single digits to low double digits, improving toward around 12-13% by 2026 Q2. Operating income remains strong (roughly $2.4B in late 2026), signaling healthy operating leverage. Net cash from operating activities has been robust across quarters (e.g., around $2.0-2.3B in several periods), while investing and financing activities produced sizable cash outflows, yielding volatile overall cash flow.

🛡️ Balance Sheet & Liquidity

Assets ($60B) exceed liabilities ($60B), but Equity attributable to the parent is negative in several quarters, indicating a leveraged balance sheet. Long-term debt runs around $42-46B, with current liabilities often in the single- to low-double-digit billions. Cash generation provides liquidity, though negative equity reduces cushion.

⚠️ Key Drivers & Risks

• Drivers: Aging population-driven inpatient demand; payer mix and volumes.
• Risks: Regulatory/reimbursement pressure; earnings volatility and persistent negative equity.